Company Filing History:
1 out of 155 
1 out of 237 Years Active: 2016-2019
Title: Sylvian Chemtob: Innovator in CCR2 Antagonist Peptides
Introduction
Sylvian Chemtob is a notable inventor based in Cote St. Luc, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of peptides that serve as CCR2 antagonists. With a total of two patents to her name, her work has implications for various therapeutic applications.
Latest Patents
Chemtob's latest patents focus on CCR2 antagonist peptides. The first patent describes a peptide that functions as a CCR2 non-competitive antagonist. The second patent details a peptide comprising the amino acid sequence Thr-Phe-Leu-Lys or Thr-Phe-Leu-Lys-Cys, which is also useful as a CCR2 non-competitive antagonist peptide. These innovations highlight her expertise in peptide design and its potential applications in medical treatments.
Career Highlights
Throughout her career, Chemtob has worked with prestigious institutions such as Université Pierre et Marie Curie and Sorbonne Université. Her research has contributed to advancements in understanding the role of CCR2 in various biological processes.
Collaborations
Some of her notable coworkers include Christophe Combadiere and Florian Sennlaub. Their collaborative efforts have furthered research in the field of peptide antagonists.
Conclusion
Sylvian Chemtob's contributions to the development of CCR2 antagonist peptides demonstrate her innovative spirit and dedication to advancing biochemistry. Her patents reflect a commitment to improving therapeutic options in medicine.